SS-31 for Muscle Growth: What the Evidence Shows
What human and animal studies show about SS-31 for muscle growth, how strong that evidence is, and what is still unproven.
- Strongest evidence
- None graded
- no study with an outcome for muscle growth (PubMed search, 11 Oct 2026)
- Human studies
- None found
- with an outcome for muscle growth, in our evidence file (PubMed search, 11 Oct 2026)
- Animal studies
- None found
- with an outcome for muscle growth, in our evidence file (PubMed search, 11 Oct 2026)
Evidence for muscle growth
None of the study abstracts we summarised for SS-31 reported an outcome for muscle growth (PubMed search, 11 Oct 2026). Claims that it helps with muscle growth are unproven.
How strong is it?
A human randomized trial outweighs any number of animal studies. Animal and cell results show a mechanism worth testing, not that it works in people.
What exercise and fitness mean
MedlinePlus calls exercise anything that gets your body moving.[8]
Strength and muscle outcomes in studies
In the Barth syndrome extension at 36 weeks, 6-minute walk and symptom scores improved, as did knee extensor strength among the secondary endpoints.[9]
The matched natural-history comparison reported a 6-minute walk difference of 79.7 m at week 64 and 91.0 m at week 76.[10]
In healthy older adults a single elamipretide dose raised mitochondrial capacity in a hand muscle but did not change resistance to fatigue.[11]
Muscle tissue in animals and the labelled use
In dogs with chronic heart failure, treatment restored a near-normal skeletal muscle fibre-type composition. This is dog data.[12]
The label indication concerns muscle strength in Barth syndrome only, and none of the cited studies tested it in healthy people for muscle size.[13]
Other peptides people research for muscle growth
All peptides for muscle growth, comparedCommon questions
Does SS-31 help with muscle growth?
None of the studies we summarised for SS-31 (PubMed search, 11 Oct 2026) measured an outcome for muscle growth. Treat claims that it helps with muscle growth as unproven.
Is SS-31 approved for muscle growth?
SS-31 is FDA accelerated approval for Barth syndrome (Sep 2025). Which conditions that approval covers is set by the label; use for anything else is off-label.
What is the best peptide for muscle growth?
There is no single answer. Our muscle growth overview compares each candidate by evidence grade and legal status rather than by popularity.
More on SS-31
Sources
- 1PubMed search: (elamipretide[tiab] OR Bendavia[tiab] OR "MTP-131"[tiab] OR Forzinity[tiab] OR (("SS-31"[tiab] OR SS31[tiab]) AND (peptide*[tiab] OR mitochondri*[tiab] OR cardiolipin[tiab] OR Szeto[tiab]))) (526 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 2PubMed search: (elamipretide[tiab] OR Bendavia[tiab] OR "MTP-131"[tiab] OR Forzinity[tiab] OR (("SS-31"[tiab] OR SS31[tiab]) AND (peptide*[tiab] OR mitochondri*[tiab] OR cardiolipin[tiab] OR Szeto[tiab]))) AND (randomized[tiab] OR trial[tiab] OR patients[tiab]) (133 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 3PubMed search: (elamipretide[tiab] OR Bendavia[tiab] OR "MTP-131"[tiab] OR Forzinity[tiab] OR (("SS-31"[tiab] OR SS31[tiab]) AND (peptide*[tiab] OR mitochondri*[tiab] OR cardiolipin[tiab] OR Szeto[tiab]))) AND (half-life[tiab] OR pharmacokinetic*[tiab]) (11 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 4PubMed search: elamipretide[tiab] AND (TAZPOWER[tiab] OR "Barth syndrome"[tiab]) AND (randomized[tiab] OR crossover[tiab]) (6 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 5PubMed search: elamipretide[tiab] AND (macular[tiab] OR "geographic atrophy"[tiab]) (9 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 6PubMed search: elamipretide[tiab] AND (fibromyalgia[tiab] OR fatigue[tiab] OR "chronic pain"[tiab]) (19 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 7PubMed search: (elamipretide[tiab] OR Bendavia[tiab] OR "MTP-131"[tiab] OR Forzinity[tiab] OR (("SS-31"[tiab] OR SS31[tiab]) AND (peptide*[tiab] OR mitochondri*[tiab] OR cardiolipin[tiab] OR Szeto[tiab]))) AND (adverse[tiab] OR "side effect*"[tiab] OR safety[tiab] OR tolerab*[tiab] OR toxicity[tiab] OR "case report"[pt]) (77 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 11 Oct 2026
- 8Official web pageOfficial web page · web page
- 9A phase 2/3 randomized clinical trial followed by an open-label extension to evaluate the effectiveness of elamipretide in Barth syndrome, a genetic disorder of mitochondrial cardiolipin metabolism.Genetics in medicine : official journal of the American College of Medical Genetics · 2021PMID 33077895Accessed 2 Oct 2026
- 10Natural history comparison study to assess the efficacy of elamipretide in patients with Barth syndrome.Orphanet journal of rare diseases · 2022PMID 36056411Accessed 2 Oct 2026
- 11In vivo mitochondrial ATP production is improved in older adult skeletal muscle after a single dose of elamipretide in a randomized trial.PloS one · 2021PMID 34264994Accessed 2 Oct 2026
- 12Effects of elamipretide on skeletal muscle in dogs with experimentally induced heart failure.ESC heart failure · 2019PMID 30688415Accessed 2 Oct 2026
- 13FORZINITY prescribing information (FDA label)FDA label, DailyMed · current labeldailymed.nlm.nih.govAccessed 2 Oct 2026
Found an error? Report a correction.